from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2032/acg

LFCtreatmentdescriptionclass of inhibitor

0.174

Amikacinug/mL Amikacintranslation

-0.241

Cap5-10ug/mL Capreomycintranslation

0.096

Rox10-50 ug/mL Roxithromycintranslation

-0.136

SM2-5 ug/mL Streptomycintranslation

0.484

Tet5-10 ug/mL Tetracyclinetranslation

0.122

Rif0.2-5ug/mL Rifampicintranscription

0.139

Rifp0.1-0.5ug/mL Rifapentinetranscription

4.849

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.150

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.015

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.217

Clofazimine10-13 ug/mL Clofaziminerespiration

0.173

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.610

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.215

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.143

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.137

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.329

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.069

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.549

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.282

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.558

KCN5-20 ug/mL Potassium cyaniderespiration

-0.663

NaN30.2-2 mM Sodium aziderespiration

-1.152

Nigericin50 uM Nigericinrespiration

-0.361

TRC10-150 ug/mL Triclosanrespiration

-0.748

TRZ10-25 ug/mL Thioridazinerespiration

-0.468

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.440

menadione6-10 ug/mL Menadionerespiration

-0.122

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.253

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.119

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.804

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

3.941

NRP_1Non-replicating persistence stage 1dosRassociated

-0.459

Amp0.2mg/mL AmpicillincellWall

-0.038

Cephalexin20-100 ug/mL CephalexincellWall

0.134

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.218

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.227

EMB10-20 ug/mL EthambutolcellWall

-0.125

Eta12-40 ug/mL EthionamidecellWall

-0.344

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.419

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.784

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.546

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.371

BZA0.12 mg/mL BenzamidearomaticAmides

-0.356

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.484

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.031

H2O24 mM hydrogen peroxideDNAdamaging

-0.223

Levo10 ug/mL LevofloxacinDNAdamaging

-0.151

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.058

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.293

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.247

UVUV-irradiationDNAdamaging

-0.575

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.112

Antimycin12.5-50 ug/mL Antimycin A?

-0.139

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.350

PA_110-50 ug/mL Antitubercular compound PA-1?

0.186

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.372

PA8240.2-2 ug/mL PA-824?

4.119

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.238

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.155

Verapamil50 uM Verapamil?

-0.605

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.485

methoxatin10-20 ug/mL Methoxatin?